Study reveals single dose of HPV vaccine can protect from cervical cancer

Image
ANI
Last Updated : Feb 15 2020 | 11:25 AM IST

HPV is the most common sexually transmitted infection in the United States, and persistent infection with certain types of the virus can cause cervical cancer. In a breakthrough study in the field, researchers indicated that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer.

To prevent infection, the Centers for Disease Control and Prevention recommended that adolescents both boys and girls under the age of 15 years receive a two-dose schedule of the HPV vaccine.

To determine the effectiveness of other dose schedules, Ana M. Rodriguez, MD, MPH, of The University of Texas Medical Branch at Galveston, and her colleagues examined information on females aged 9 to 26 years who were unvaccinated or who received one or more HPV vaccine doses between January 2006 and June 2015.

The findings of the research are published early online in 'CANCER', a peer-reviewed journal of the American Cancer Society (ACS).

The analysis included 133,082 females (66,541 vaccinated and 66,541 unvaccinated). For females ages, 15 to 19 years, those who received one, two, or three doses of the HPV vaccine had lower rates of preinvasive cervical disease than adolescents who were unvaccinated. Within five years, 2.65 per cent of unvaccinated teens aged 15 to 19 years developed the preinvasive cervical disease, compared with 1.62 per cent, 1.99 per cent, and 1.86 per cent in the one-, two- and three-dose groups, respectively.

he risk of preinvasive cervical disease was 36 per cent, 28 per cent, and 34 per cent lower for adolescents who received one, two, and three doses, respectively, compared with adolescents who were unvaccinated.

For the youngest (less than 15 years old) and oldest age groups (20 years and older), the investigators did not find significant differences among the vaccinated groups in terms of risk for preinvasive cervical disease.

Dr. Rodriguez said, "This study shows the impact of vaccinating at younger ages and its lasting long-term protection against cervical cancer. It is important to educate parents about the need to vaccinate their children.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 15 2020 | 10:55 AM IST

Next Story